According to the latest data from the Hong Kong Stock Exchange, on September 21, Lazard Asset Management LLC reduced its holdings in Sinopharm (01099) by 738,800 shares at a price of HK$15.1035 per share, for a total amount of approximately HK$11.1585 million.
Following the reduction, its latest shareholding stands at approximately 188 million shares, representing a latest shareholding ratio of 13.99%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.